APIMEDS
Apimeds is a biotechnology company that specializes in bee venom component drug development.
APIMEDS
Industry:
Biopharma Biotechnology
Founded:
2003-09-01
Status:
Active
Contact:
+82 2 6951 1230
Technology used in webpage:
SPF Font Awesome PHP Korea Telecom Gnuboard
Similar Organizations
APITBIO
APITBIO is a biotech company that specializes in antibody therapeutics research and development.
BiSiChem
BiSiChem is a biotechnology company that focuses on the drug discovery and development field.
Genevide
Genevide is a biotech company that specializes in gene research and development.
ILIAS Biologics
ILIAS Biologics is a biotechnology company that specializes in therapeutic molecules.
Moogene Medi
Moogene Medi is a biotechnology company that specializes in gene therapy and development of drug delivery systems using nano-bio technology.
Vipragen Biosciences
Vipragen Biosciences is a biotechnology company that specializes in Pharmaceuticals & drug development.
Investments List
| Date | Company | Article | Money raised |
|---|---|---|---|
| 2021-10-01 | Cellaputics Bio | Apimeds investment in Seed Round - Cellaputics Bio | N/A |
More informations about "Apimeds"
Apimeds
Stem School of Business, NYU. HYUKJAE LEE (CFO, ApiMeds Korea/Inscobee) Roles at BIEMT Co Samil Pricewaterhouse Coopers, Samsung Electronics, and Morgan Stanley University of โฆSee details»
Apimeds Pharmaceutical US, Inc
Apimeds works in concert with national support societies to provide patients with the broadest range of information and updates. Please see below to research more about Osteoarthritis and/or Multiple Sclerosis.See details»
Apimeds Pharmaceuticals US, Inc (APUS) - Yahoo Finance Canada
See the company profile for Apimeds Pharmaceuticals US, Inc (APUS) including business summary, industry/sector information, number of employees, business summary, corporate โฆSee details»
์กฐ์ง๋ | ์ํผ๋ฉ์ฆ - Apimeds
JAKAP KOO (CEO & President, ApiMeds Korea/Inscobee) 35 years mostly as C-level executives in various financial institutions and IT companies. Management and operational experiences โฆSee details»
Organization | Apimeds
Targets and Mechanisms Alternative names Apimeds, CEO | Apimeds, Inc. | Apimeds, Inc, US Chief Operating OfficerSee details»
Apimeds Pharmaceuticals US (APUS) Company Profile & Description
Company profile for Apimeds Pharmaceuticals US, Inc. (APUS) stock, with a description, list of executives, contact details and other key facts.See details»
Apimeds, Inc. - Drug pipelines, Patents, Clinical trials - Synapse
Explore Apimeds, Inc. with its drug pipeline, therapeutic area, technology platform, 3 clinical trials, 1 news, Technology Platform:Toxin, Drug:Bee venom (Apimeds Co ...See details»
Apimeds - Crunchbase Investor Profile & Investments
Apimeds is a biotechnology company that specializes in bee venom component drug development.See details»
Apimeds
About Apimeds Apimeds opens up a harmonious future in various fields of business.See details»
Apimeds Pharmaceuticals US, Inc. - Dun & Bradstreet
Find company research, competitor information, contact details & financial data for Apimeds Pharmaceuticals US, Inc. of Hopewell, NJ. Get the latest business insights from Dun & โฆSee details»
Apimeds Pharmaceuticals US | IPOScoop
Apimeds Pharmaceuticals US | IPOScoopApimeds Pharmaceuticals USSee details»
Apimeds 2025 Company Profile: Valuation, Funding & Investors
Information on valuation, funding, acquisitions, investors, and executives for Apimeds. Use the PitchBook Platform to explore the full profile.See details»
Apimeds - VentureRadar
Apimeds develops biotherapeutics, medical devices, and edible vaccines. ... Find out more about Apimeds, Biotech.See details»
Apimeds Pharmaceuticals US: APUS IPO, Health Care - Clinical โฆ
Sep 25, 2024 IPO: Apimeds Pharmaceuticals US (APUS) - Clinical stage biotech developing bee venom-based treatment for inflammation. - Health Care - Renaissance CapitalSee details»
Apimeds - Investments, Portfolio & Company Exits - Crunchbase
Oct 1, 2021 Apimeds is a biotechnology company that specializes in bee venom component drug development.See details»
Apimeds
Apimeds, Inc. is leading the discovery of new growth engines in various fields of business, is concentrating its capabilities to grow into an excellent company.See details»
APIMEDS, Inc. - Company Profile
Apimeds is a biomedical company established in September, 2003. Over the last 20 years of R&D on MS, Pain & Inflammation, Apimeds has already established a global level of technology โฆSee details»
Apimeds
Apimeds, Inc. is a bio company that makes human happiness through life science. Opened in May 2020, Apimeds Research Institute is a company specialising in the development of new drugs โฆSee details»
Apimeds
Apimeds opens up a harmonious future in various fields of business.See details»
Apimeds
Apimeds, Inc. will contribute to the improvement of human health and quality of life, and will lead the future strategic industry, the life science industry. We sincerely thank our shareholders and โฆSee details»